Online Media Kit
FEATURED STORY
March 16, 2022 | Times LIVE (South Africa)
The South African Health Products Regulatory Authority (SAHPRA) okayed the use of the monthly dapivirine vaginal ring by adult women.
FEATURED STORY
February 26, 2022 | The East African (Kenya)
Given a choice between two HIV prevention products, most adolescent girls and young women who had used both products while participating in the REACH study chose the monthly dapivirine ring.
FEATURED STORY
January 26, 2021 | World Health Organization
WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as...
Media Highlights
December 01, 2020 | Johnson & Johnson on LinkedIn
Paul Stoffels highlights progress made by Johnson & Johnson's partners in HIV/AIDS, including the WHO prequalification of the dapivirine ring.
December 01, 2020 | Die Zeit (Germany)
A look at the role the dapivirine ring could play in helping women to reduce their HIV risk.
December 01, 2020 | Times LIVE (South Africa)
WHO prequalification for the dapivirine ring will help guide national and global procurement decisions, pending each country's regulatory approvals.
November 30, 2020 | Gates Foundation blog
This op-ed discusses the promise of long-acting HIV prevention products for women and the need for investment and collaboration to develop and make multiple options available.
November 30, 2020 | New York Times
The World Health Organization approved the dapivirine ring, a vaginal insert that has proved effective in women who use it consistently. Finding prevention methods that women can use discreetly has...